Showing results (321-330 of 458) with videos related to

Sort By:
Pageof 46
Bone Marrow Transplantation|March 2, 2011
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USAK W Douglas, A N Parker, P J Hayden, et al.
Cancer Research|October 12, 2010
Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapyDavid C Delgado, Jacquelyn A Hank, Jill Kolesar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Molecular characterization of the pediatric preclinical testing panelGeoffrey Neale, Xiaoping Su, Christopher L Morton, et al.
International Journal of Molecular Imaging|October 11, 2012
Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology GroupSteven G Dubois, Ethan Geier, Vandana Batra, et al.
Pediatric Blood & Cancer|April 7, 2017
MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology GroupSteven G DuBois, Rajen Mody, Arlene Naranjo, et al.
Cancer Research Communications|November 16, 2022
Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastomaKateryna Krytska, Colleen E Casey, Jennifer Pogoriler, et al.
Pediatric Blood & Cancer|June 1, 2024
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531Erin K Barr, Arlene Naranjo, Clare J Twist, et al.
Pediatric Blood & Cancer|May 7, 2011
Testing of the topoisomerase 1 inhibitor Genz-644282 by the pediatric preclinical testing programPeter J Houghton, Richard Lock, Hernan Carol, et al.
Cancer Research|August 7, 2016
Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse AnalysisBrendan Murphy, Han Yin, John M Maris, et al.
Pediatric Blood & Cancer|September 17, 2013
Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing ProgramHernan Carol, Richard Gorlick, E Anders Kolb, et al.
Pageof 46